Use of a novel cell surface protease from group b streptococcus

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/02 (2006.01) A61K 39/09 (2006.01) C07H 21/04 (2006.01) C07K 2/00 (2006.01) C07K 14/315 (2006.01) C07K 16/00 (2006.01) C12N 1/20 (2006.01) C12N 5/10 (2006.01) C12N 9/52 (2006.01) C12N 15/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2470421

This invention relates to use of a novel cell surface protease protein of Group B Streptococcus (GBS), called CspA, as a vaccine to prevent GBS infection.

La présente invention concerne l'utilisation d'une nouvelle protéine protéase de surface cellulaire du groupe streptococcus (gbs), appelée cspa, comme vaccin destiné à prévenir l'infection par le gbs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of a novel cell surface protease from group b streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a novel cell surface protease from group b streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a novel cell surface protease from group b streptococcus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1638204

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.